DiaMedica Therapeutics (DMAC) EBT (2018 - 2019)
Historic EBT for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q4 2019 value amounting to -$2.5 million.
- DiaMedica Therapeutics' EBT fell 2668.71% to -$2.5 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$10.6 million, marking a year-over-year decrease of 8779.63%. This contributed to the annual value of -$24.4 million for FY2024, which is 2624.88% down from last year.
- Latest data reveals that DiaMedica Therapeutics reported EBT of -$2.5 million as of Q4 2019, which was down 2668.71% from -$2.4 million recorded in Q3 2019.
- DiaMedica Therapeutics' 5-year EBT high stood at -$649000.0 for Q1 2018, and its period low was -$3.2 million during Q1 2019.